Assay and Drug Development Technologies

Published by: Mary Ann Liebert, Inc  

Groups

  1. Sloan Kettering Institute Postdocs (13)
  2. GSK Faculty (4)
  3. Molecular Pharmacology and Chemistry Program Faculty (4)
  4. Sloan Kettering Institute Faculty (4)
  5. Center for Hematologic Malignancies (3)
  6. Hematologic Malignancies Research (3)
  7. Adult Leukemia (2)
  8. Central Nervous System Disease Management Team (2)
  9. Hematologic Malignancies, Division of (2)
  10. Surgery (2)
Search Within
Refine Results

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assay and Drug Development Technologies – authorized name for:

    Name ISSN / ISBN Publisher
    Assay and Drug Development Technologies 1540658X Mary Ann Liebert, Inc
    Assay and Drug Development Technologies 1540-658X Mary Ann Liebert, Inc
    Assay and Drug Development Technologies 1540-658X Mary Ann Liebert, Inc
    Assay and Drug Development Technologies 1540658X Mary Ann Liebert, Inc
    ASSAY and Drug Development Technologies 1540-658X Unknown
    Assay and Drug Development Technologies 1540-658X Mary Ann Liebert, Inc
    Assay and Drug Development Technologies 1540658X Unknown
    Assay and Drug Development Technologies 1540658X Mary Ann Liebert, Inc
    Assay and Drug Development Technologies 1540658X Mary Ann Liebert, Inc